Primary hemophagocytic lymphohistiocytosis (HLH) is a rare, life-threatening disease that can be difficult to diagnose.1 View the patient case videos below to see how primary HLH was identified in real patients and explore the treatment plans that helped condition them for hematopoietic stem cell transplantation (HSCT).
Mack’s journey—primary HLH induced by EBV
Mack’s journey—primary HLH induced by EBV
Mack was admitted to the emergency room and diagnosed with Epstein-Barr virus (EBV). When his symptoms worsened, Mack's treatment team began to suspect that primary HLH could be responsible. See how Mack's treatment team discovered he had primary HLH and how Gamifant fit into the treatment plan that conditioned him for HSCT.
View the Mack Patient Case Brochure
Camden’s journey—primary HLH in a newborn baby
While pregnant, Camden's mother suffered from persistent fevers. At birth, Camden presented with "blueberry muffin spots" due to pancytopenia and severe ascites. See how Camden’s treatment team discovered he had primary HLH and how Gamifant fit into the treatment plan that conditioned him for HSCT.
View the Camden Patient Case BrochureContact A HEALTH SYSTEMS DIRECTOR FOR ADDITIONAL QUESTIONS
Contact A HEALTH SYSTEMS DIRECTOR FOR ADDITIONAL QUESTIONSNS